Skip to main content
SpringerLink
Log in

The Control of ESBL-Producing Bacteria

  • Chapter
  • First Online:
Antibiotic Policies

  • 1771 Accesses

Abstract

Infections caused by Extended Spectrum Beta Lactamase (ESBL) producing Gram-negative bacteria have emerged over the last twenty years as a major worldwide problem for treatment. Initially the ESBL enzymes of the TEM and SHV type were identified, these did not reach high rates and were most common in Klebsiella spp rather than E.coli. ESBLs of the CTX-M type have become the most common and widespread type particularly in community strains of E.coli. Faecal colonisation in both infected patients and asymptomatic carriers is the most important source so successful infection control measures are directed at reducing spread from that source. Antibiotic restriction has been demonstrated to control the rate of ESBLs, reduction in third generation cephalosporins and quinolones having the greatest impact when combined with source control/hand washing as infection control interventions. Substitution of these selective agents by piperacillin/tazobactam and carbapenems results in ESBL reduction particularly if combined with use of a diversity of other narrow spectrum agents. There are widely differing rates of ESBLs around the world which broadly correlates with the overall hospital/community prescription, agricultural and over the counter usage of quinolones and cephalosporins. Application of antibiotic stewardship is an important control measure when supported by control of the sources and routes of spread of ESBL-producing Enterobacteriaceae.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akram, M., Shahid, M., & Khan, A.U. 2007. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann.Clin.Microbiol.Antimicrob., 6, 4

    Article  PubMed  Google Scholar 

  • Al Naimeri N., Heddema, E.R., Bart, A., de, J.E., Vandenbroucke-Grauls, C.M., Savelkoul, P.H., & Duim, B. 2006. Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J.Antimicrob.Chemother., 58, 853-856

    Google Scholar 

  • Arda, B., Sipahi, O.R., Yamazhan, T., Tasbakan, M., Pullukcu, H., Tunger, A., Buke, C., & Ulusoy, S. 2007. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J.Infect., 55, 41-48

    Article  PubMed  Google Scholar 

  • Asensio, A., Oliver, A., Gonzalez-Diego, P., Baquero, F., Perez-Diaz, J.C., Ros, P., Cobo, J., Palacios, M., Lasheras, D., & Canton, R. 2000. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin.Infect.Dis., 30, 55-60

    Article  PubMed  CAS  Google Scholar 

  • Ben-Ami, R., Schwaber, M.J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., & Carmeli, Y. 2006. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin.Infect.Dis., 42, 925-934

    Article  PubMed  CAS  Google Scholar 

  • Blanco, M., Alonso, M.P., Nicolas-Chanoine, M.H., Dahbi, G., Mora, A., Blanco, J.E., Lopez, C., Cortes, P., Llagostera, M., Leflon-Guibout, V., Puentes, B., Mamani, R., Herrera, A., Coira, M.A., Garcia-Garrote, F., Pita, J.M., & Blanco, J. 2009. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J.Antimicrob.Chemother., 63, 1135-1141

    Article  PubMed  CAS  Google Scholar 

  • Casewell, M.W., Dalton, M.T., Webster, M., & Phillips, I. 1977. Gentamicin-resistant Klebsiella aerogenes in a urological ward. Lancet, 2, (8035) 444-446

    Article  PubMed  CAS  Google Scholar 

  • Castanheira, M., Mendes, R.E., Rhomberg, P.R., & Jones, R.N. 2008. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007). Microb.Drug Resist., 14, 211-216

    Article  PubMed  CAS  Google Scholar 

  • Cattoir, V. & Nordmann, P. 2009. Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. Curr.Med.Chem., 16, 1028-1046

    Article  PubMed  CAS  Google Scholar 

  • Cavaco, L.M., Frimodt-Moller, N., Hasman, H., Guardabassi, L., Nielsen, L., & Aarestrup, F.M. 2008. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark. Microb.Drug Resist., 14, 163-169

    Article  PubMed  CAS  Google Scholar 

  • Chanawong, A., M’Zali, F.H., Heritage, J., Xiong, J.H., & Hawkey, P.M. 2002. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People’s Republic of China. Antimicrob.Agents Chemother., 46, 630-637

    Article  PubMed  CAS  Google Scholar 

  • den Heijer, C.D., Donker, G.A., Maes, J., & Stobberingh, E.E. 2010. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J.Antimicrob.Chemother., 65, 2128-2133

    Article  Google Scholar 

  • Dierikx, C., van Essen-Zandbergen, A., Veldman, K., Smith, H., & Mevius, D. 2010. Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet.Microbiol., 145, 273-278

    Article  PubMed  CAS  Google Scholar 

  • Du, B., Long, Y., Liu, H., Chen, D., Liu, D., Xu, Y., & Xie, X. 2002. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med., 28, 1718-1723

    Article  PubMed  Google Scholar 

  • Ensor, V.M., Shahid, M., Evans, J.T., & Hawkey, P.M. 2006. Occurrence, prevalence and genetic environment of CTX-M -lactamases in Enterobacteriaceae from Indian hospitals. J.Antimicrob.Chemother., 58, 1260-1263

    Article  PubMed  CAS  Google Scholar 

  • Gaze, W., O’Neill, C., Wellington, E., & Hawkey, P. 2008. Antibiotic resistance in the environment, with particular reference to MRSA. Adv.Appl.Microbiol., 63C, 249-280

    Google Scholar 

  • Gaze, W.H., Abdouslam, N., Hawkey, P.M., & Wellington, E.M. 2005. Incidence of class 1 integrons in a quaternary ammonium compound-polluted environment. Antimicrob.Agents Chemother., 49, 1802-1807

    Article  PubMed  CAS  Google Scholar 

  • Giske, C.G., Sundsfjord, A.S., Kahlmeter, G., Woodford, N., Nordmann, P., Paterson, D.L., Canton, R., & Walsh, T.R. 2009. Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J.Antimicrob.Chemother., 63, 1–4

    Article  PubMed  CAS  Google Scholar 

  • Gray, K.J., Wilson, L.K., Phiri, A., Corkill, J.E., French, N., & Hart, C.A. 2006. Identification and characterization of ceftriaxone resistance and extended-spectrum beta-lactamases in Malawian bacteraemic Enterobacteriaceae. J.Antimicrob.Chemother., 57, 661-665

    Article  PubMed  CAS  Google Scholar 

  • Harris, A.D., Karchmer, T.B., Carmeli, Y., & Samore, M.H. 2001. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin.Infect.Dis., 32, 1055–1061

    Article  PubMed  CAS  Google Scholar 

  • Harris, A.D., Kotetishvili, M., Shurland, S., Johnson, J.A., Morris, J.G., Nemoy, L.L., & Johnson, J.K. 2007a. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am.J.Infect.Control., 35, 97-101

    Article  Google Scholar 

  • Harris, A.D., McGregor, J.C., Johnson, J.A., Strauss, S.M., Moore, A.C., Standiford, H.C., Hebden, J.N., & Morris, J.G., Jr. 2007b. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg.Infect.Dis., 13, 1144-1149

    Article  Google Scholar 

  • Hawkey, P.M. & Jones, A.M. 2009. The changing epidemiology of resistance. J.Antimicrob.Chemother., 64 Suppl 1:, i3-10

    Article  PubMed  CAS  Google Scholar 

  • Hyle, E.P., Gasink, L.B., Linkin, D.R., Bilker, W.B., & Lautenbach, E. 2007. Use of different thresholds of prior antimicrobial use in defining exposure: impact on the association between antimicrobial use and antimicrobial resistance. J.Infect., 55, 414-418

    Article  PubMed  Google Scholar 

  • Kim, J.Y., Sohn, J.W., Park, D.W., Yoon, Y.K., Kim, Y.M., & Kim, M.J. 2008. Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use. J.Antimicrob.Chemother., 62, 416-421

    Google Scholar 

  • Knothe, H., Shah, P., Krcmery, V., Antal, M., & Mitsuhashi, S. 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection, 11, 315-317

    Article  PubMed  CAS  Google Scholar 

  • Larson, E.L., Quiros, D., Giblin, T., & Lin, S. 2007. Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates. Am.J.Crit Care., 16, 110-120

    PubMed  Google Scholar 

  • Lautenbach, E., Patel, J.B., Bilker, W.B., Edelstein, P.H., & Fishman, N.O. 2001. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin.Infect.Dis., 32, 1162-1171

    Article  PubMed  CAS  Google Scholar 

  • Lee, J., Pai, H., Kim, Y.K., Kim, N.H., Eun, B.W., Kang, H.J., Park, K.H., Choi, E.H., Shin, H.Y., Kim, E.C., Lee, H.J., & Ahn, H.S. 2007. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children’s hospital by changing antimicrobial agent usage policy. J.Antimicrob.Chemother., 60, 629-637

    Article  PubMed  CAS  Google Scholar 

  • Lipworth, A.D., Hyle, E.P., Fishman, N.O., Nachamkin, I., Bilker, W.B., Marr, A.M., Larosa, L.A., Kasbekar, N., & Lautenbach, E. 2006. Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect.Control Hosp.Epidemiol., 27, 279-286

    Article  PubMed  Google Scholar 

  • MacAdam, H., Zaoutis, T.E., Gasink, L.B., Bilker, W.B., & Lautenbach, E. 2006. Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use. Int.J.Antimicrob.Agents., 28, 325-332

    Article  PubMed  CAS  Google Scholar 

  • Martinez-Martinez, L., Pascual, A., & Jacoby, G.A. 1998. Quinolone resistance from a transferable plasmid. Lancet., 351, 797-799

    Article  PubMed  CAS  Google Scholar 

  • Meyer, K.S., Urban, C., Eagan, J.A., Berger, B.J., & Rahal, J.J. 1993. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann.Intern.Med., 119, 353-358

    PubMed  CAS  Google Scholar 

  • Munday, C.J., Whitehead, G.M., Todd, N.J., Campbell, M., & Hawkey, P.M. 2004a. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. J.Antimicrob.Chemother., 54, 628-633

    Article  CAS  Google Scholar 

  • Munday, C.J., Xiong, J., Li, C., Shen, D., & Hawkey, P.M. 2004b. Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People’s Republic of China. Int.J.Antimicrob.Agents, 23, 175-180

    Article  CAS  Google Scholar 

  • Ndugulile, F., Jureen, R., Harthug, S., Urassa, W., & Langeland, N. 2005. Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania. BMC.Infect.Dis., 5, 86

    Article  PubMed  Google Scholar 

  • Nicolas-Chanoine, M.H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M.P., Canica, M.M., Park, Y.J., Lavigne, J.P., Pitout, J., & Johnson, J.R. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J.Antimicrob.Chemother., 61, 273–281

    Google Scholar 

  • Oostdijk, E.A., de Smet, A.M., Blok, H.E., Thieme Groen, E.S., van Asselt, G.J., Benus, R.F., Bernards, S.A., Frenay, I.H., Jansz, A.R., de Jongh, B.M., Kaan, J.A., Leverstein-van Hall, M.A., Mascini, E.M., Pauw, W., Sturm, P.D., Thijsen, S.F., Kluytmans, J.A., & Bonten, M.J. 2010. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am.J.Respir.Crit Care Med., 181, 452-457

    Article  PubMed  Google Scholar 

  • Papanicolaou, G.A., Medeiros, A.A., & Jacoby, G.A. 1990. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob.Agents Chemother., 34, 2200-2209

    Google Scholar 

  • Paterson, D.L. & Bonomo, R.A. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin.Microbiol.Rev., 18, 657-686

    Article  PubMed  CAS  Google Scholar 

  • Paterson, D.L., Ko, W.C., Von Gottberg, A., Mohapatra, S., Casellas, J.M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K.P., Bonomo, R.A., Rice, L.B., Wagener, M.M., McCormack, J.G., & Yu, V.L. 2004. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann.Intern.Med., 140, 26-32

    PubMed  Google Scholar 

  • Paterson, D.L., Mulazimoglu, L., Casellas, J.M., Ko, W.C., Goossens, H., Von Gottberg, A., Mohapatra, S., Trenholme, G.M., Klugman, K.P., McCormack, J.G., & Yu, V.L. 2000a. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin.Infect.Dis., 30, 473-478

    Article  CAS  Google Scholar 

  • Patterson, J.E., Hardin, T.C., Kelly, C.A., Garcia, R.C., & Jorgensen, J.H. 2000b. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect.Control Hosp.Epidemiol., 21, 455-458

    Article  CAS  Google Scholar 

  • Pessoa-Silva, C.L., Meurer, M.B., Camara, A., V, Flannery, B., Almeida Lins, M.C., Mello Sampaio, J.L., Martins, T.L., Vaz Miranda, L.E., Riley, L.W., & Gerberding, J.L. 2003. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J.Hosp.Infect., 53, 198-206

    Google Scholar 

  • Philippon, A., Arlet, G., & Jacoby, G.A. 2002. Plasmid-determined AmpC-type beta-lactamases. Antimicrob.Agents Chemother., 46, (1) 1-11

    Article  PubMed  CAS  Google Scholar 

  • Philippon, A., Labia, R., & Jacoby, G. 1989. Extended-spectrum beta-lactamases. Antimicrob.Agents Chemother., 33, 1131-1136

    Article  PubMed  CAS  Google Scholar 

  • Rahal, J.J., Urban, C., Horn, D., Freeman, K., Segal-Maurer, S., Maurer, J., Mariano, N., Marks, S., Burns, J.M., Dominick, D., & Lim, M. 1998. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA, 280, 1233-1237

    Article  PubMed  CAS  Google Scholar 

  • Rice, L.B., Eckstein, E.C., DeVente, J., & Shlaes, D.M. 1996. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin.Infect.Dis., 23, 118-124

    Article  PubMed  CAS  Google Scholar 

  • Rice, L.B., Willey, S.H., Papanicolaou, G.A., Medeiros, A.A., Eliopoulos, G.M., Moellering, R.C., Jr., & Jacoby, G.A. 1990. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob.Agents Chemother., 34,

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez-Bano, J., Navarro, M.D., Romero, L., Muniain, M.A., de Cueto, M., Rios, M.J., Hernandez, J.R., & Pascual, A. 2006. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin.Infect.Dis., 43, 1407-1414

    Article  PubMed  Google Scholar 

  • Rodriguez-Bano, J., Picon, E., Gijon, P., Hernandez, J.R., Ruiz, M., Pena, C., Almela, M., Almirante, B., Grill, F., Colomina, J., Gimenez, M., Oliver, A., Horcajada, J.P., Navarro, G., Coloma, A., & Pascual, A. 2010. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin.Infect.Dis., 50, 40-48

    Article  PubMed  CAS  Google Scholar 

  • Rooney, P.J., O’Leary, M.C., Loughrey, A.C., McCalmont, M., Smyth, B., Donaghy, P., Badri, M., Woodford, N., Karisik, E., & Livermore, D.M. 2009. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J.Antimicrob.Chemother., 64, 635-641

    Article  PubMed  CAS  Google Scholar 

  • Sanders, C.C. 1987. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu.Rev.Microbiol., 41, 573-593

    Article  PubMed  CAS  Google Scholar 

  • Sandiumenge, A., Diaz, A., Rodriguez, L., Vidaur, L., Canadell, M., Olona, M. Rue & J Rello. 2006. Impact of diversity of antibiotic use on development of antimicrobial resistance. J. Antimicrob. Chemother. 57: 1197-1204

    Google Scholar 

  • Saurina, G., Quale, J.M., Manikal, V.M., Oydna, E., & Landman, D. 2000. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J.Antimicrob.Chemother., 45, 895-898

    Article  PubMed  CAS  Google Scholar 

  • Sirot, D. 1995. Extended-spectrum plasmid-mediated beta-lactamases. J.Antimicrob.Chemother., 36 Suppl A:19-34.,

    Article  PubMed  CAS  Google Scholar 

  • Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-Michaud, A., Perroux, R., & Cluzel, R. 1987. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J.Antimicrob.Chemother., 20, 323-334

    Article  PubMed  CAS  Google Scholar 

  • Urbanek, K., Kolar, M., Loveckova, Y., Strojil, J., & Santava, L. 2007. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J.Clin.Pharm.Ther., 32, 403-408

    Article  PubMed  CAS  Google Scholar 

  • Valverde, A., Coque, T.M., Sanchez-Moreno, M.P., Rollan, A., Baquero, F., & Canton, R. 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J.Clin.Microbiol., 42, (10) 4769-4775

    Article  PubMed  CAS  Google Scholar 

  • Warren, R.E., Harvey, G., Carr, R., Ward, D., & Doroshenko, A. 2008. Control of infections due to extended-spectrum beta-lactamase-producing organisms in hospitals and the community. Clin.Microbiol.Infect., 14 Suppl 1, 124-133

    Google Scholar 

  • Wener, K.M., Schechner, V., Gold, H.S., Wright, S.B., & Carmeli, Y. 2010. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob.Agents Chemother., 54, 2010-2016

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Immunology and Infection, University of Birmingham, B15 2TT, Edgbaston, Birmingham, UK

    Peter M. Hawkey

Authors
  1. Peter M. Hawkey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter M. Hawkey .

Editor information

Editors and Affiliations

  1. Medical School, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom

    Ian M. Gould

  2. University Hospital Nijmegen, Nijmegen, Netherlands

    Jos W.M. van der Meer

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hawkey, P.M. (2012). The Control of ESBL-Producing Bacteria. In: Gould, I., van der Meer, J. (eds) Antibiotic Policies. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1734-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1734-8_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1733-1

  • Online ISBN: 978-1-4419-1734-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation